Skip to main content
Erschienen in: Pediatric Nephrology 9/2005

01.09.2005 | Original Article

Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome

verfasst von: Aydın Ece, Yıldız Atamer, Fuat Gürkan, Mehmet Davutoğlu, Yüksel Koçyiğit, Murat Tutanç

Erschienen in: Pediatric Nephrology | Ausgabe 9/2005

Einloggen, um Zugang zu erhalten

Abstract

Reactive oxygen species (ROS) are reported to play a role in inducing the proteinuria of nephrotic syndrome (NS). This study investigated paraoxonase (PON), total antioxidant response (TAR), and oxidant total peroxide together with serum proteins and lipoproteins in children with steroid-sensitive NS. The study included 40 children with steroid-sensitive NS (21 with acute-period NS in group I, 19 nonproteinuric while receiving steroids in group II) and 22 sex- and age-matched formerly nephrotic children in remission weaned from steroids (group III). The following parameters were determined: total peroxide, oxidative stress index (OSI), PON and TAR. Serum proteins and lipoproteins were also determined. Patients in the active phase of NS had significantly lower PON and TAR levels and higher OSI and total peroxide values than those in full remission; no differences were found in PON, TAR, or OSI values of groups I and II. Significant correlations were found between PON, TAR, and total peroxide. Serum total protein had a significantly positive correlation with PON and negative correlation with total peroxide in acute-period NS patients. Our results demonstrate greater oxidative stress and decreased antioxidants in the active phase of steroid-sensitive NS and while patients receive steroids than during full remission. Low-dose alternate-day steroids do not seem to decrease oxidative stress even while proteinuria ceases. Despite some conflicting data increased oxidation and/or decreased antioxidant response may be related to the pathogenesis of steroid-sensitive NS.
Literatur
1.
Zurück zum Zitat International study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561–564PubMed International study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561–564PubMed
2.
Zurück zum Zitat Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60:242–247PubMed Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60:242–247PubMed
3.
Zurück zum Zitat Diamond JR, Bonventre JV, Karnovsky MJ (1986) A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29:478–483PubMed Diamond JR, Bonventre JV, Karnovsky MJ (1986) A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29:478–483PubMed
4.
Zurück zum Zitat Zima T, Tesar V, Stipek S, Crkovska J, Poledne R, Teminova J, Platenik J, Rychlik I, Merta M, Nemecek K (1997) The influence of cyclosporin on lipid peroxidation and superoxide dismutase in adriamycin nephropathy in rats. Nephron 75:464–469PubMed Zima T, Tesar V, Stipek S, Crkovska J, Poledne R, Teminova J, Platenik J, Rychlik I, Merta M, Nemecek K (1997) The influence of cyclosporin on lipid peroxidation and superoxide dismutase in adriamycin nephropathy in rats. Nephron 75:464–469PubMed
5.
Zurück zum Zitat Ece A, Atamer Y, Gürkan F, Bilici M, Koçyiğit Y (2004) Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome. Nephrology 9:366–373CrossRefPubMed Ece A, Atamer Y, Gürkan F, Bilici M, Koçyiğit Y (2004) Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome. Nephrology 9:366–373CrossRefPubMed
6.
Zurück zum Zitat Keane WF, Kasiske BL, O’Donnel MP (1998) Lipids and progressive glomerulo-sclerosis: a model analogous to atherosclerosis. Am J Nephrol 8:261–271CrossRef Keane WF, Kasiske BL, O’Donnel MP (1998) Lipids and progressive glomerulo-sclerosis: a model analogous to atherosclerosis. Am J Nephrol 8:261–271CrossRef
7.
Zurück zum Zitat Solin ML, Ahola H, Haltia A, Ursini F, Montine T, Roveri A, Kerjaschki D, Holthofer H (2001) Lipid peroxidation in human proteinuric disease. Kidney Int 59:481–487CrossRefPubMed Solin ML, Ahola H, Haltia A, Ursini F, Montine T, Roveri A, Kerjaschki D, Holthofer H (2001) Lipid peroxidation in human proteinuric disease. Kidney Int 59:481–487CrossRefPubMed
8.
Zurück zum Zitat Orzechowski A, Ostaszewski P, Wilczak J, Jank M, Balasinska B, Wareski P, Fuller J Jr (2002) Rats with a glucocorticoid-induced catabolic state show symptoms of oxidative stress and spleen atrophy: the effects of age and recovery. J Vet Med A Physiol Pathol Clin Med 49:256–263 Orzechowski A, Ostaszewski P, Wilczak J, Jank M, Balasinska B, Wareski P, Fuller J Jr (2002) Rats with a glucocorticoid-induced catabolic state show symptoms of oxidative stress and spleen atrophy: the effects of age and recovery. J Vet Med A Physiol Pathol Clin Med 49:256–263
9.
Zurück zum Zitat Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T (2003) Glucorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92:81–87CrossRefPubMed Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T (2003) Glucorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92:81–87CrossRefPubMed
10.
Zurück zum Zitat Mackness MI, Mackness B, Durrington PN, Connely PW, Hegele RA (1996) Paraoxonase: biochemistry, genetics and relationship to plasma proteins. Curr Opin Lipidol 7:69–76PubMed Mackness MI, Mackness B, Durrington PN, Connely PW, Hegele RA (1996) Paraoxonase: biochemistry, genetics and relationship to plasma proteins. Curr Opin Lipidol 7:69–76PubMed
11.
Zurück zum Zitat Furlong CE, Richter RJ, Seidel SL, Costa LG, Matulsky AG (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242–247CrossRefPubMed Furlong CE, Richter RJ, Seidel SL, Costa LG, Matulsky AG (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242–247CrossRefPubMed
12.
Zurück zum Zitat Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119 Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119
13.
Zurück zum Zitat Miyazawa T (1989) Determination of phospholipids hydroperoxides in human blood plasma by a chemiluminesence’s-HPLC assay. Free Radic Biol Med 7:209–217CrossRefPubMed Miyazawa T (1989) Determination of phospholipids hydroperoxides in human blood plasma by a chemiluminesence’s-HPLC assay. Free Radic Biol Med 7:209–217CrossRefPubMed
14.
Zurück zum Zitat Mackness MI, Harty D, Bahtnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN (1991) Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 86:193–199PubMed Mackness MI, Harty D, Bahtnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN (1991) Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 86:193–199PubMed
15.
Zurück zum Zitat Turi S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B, Nagy J (1997) Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22:161–168CrossRefPubMed Turi S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B, Nagy J (1997) Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22:161–168CrossRefPubMed
16.
Zurück zum Zitat Yoshioka T, Ichikawa J, Fogo A (1991) Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 2:902–912PubMed Yoshioka T, Ichikawa J, Fogo A (1991) Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 2:902–912PubMed
17.
Zurück zum Zitat Alfrey AC (1994) Role of iron and oxygen radicals in the progression of chronic renal failure. Am J Kidney Dis 23:183–187PubMed Alfrey AC (1994) Role of iron and oxygen radicals in the progression of chronic renal failure. Am J Kidney Dis 23:183–187PubMed
18.
Zurück zum Zitat Kawaguchi M, Yamada M, Wada H, Okigaki T (1992) Roles of active oxygen species in glomerular epithelial cell injury in vitro caused by puromycin aminonucleoside. Toxicology 72:329–340CrossRefPubMed Kawaguchi M, Yamada M, Wada H, Okigaki T (1992) Roles of active oxygen species in glomerular epithelial cell injury in vitro caused by puromycin aminonucleoside. Toxicology 72:329–340CrossRefPubMed
19.
Zurück zum Zitat Gwinner W, Landmesser U, Brandes RP, Kubat B, Plasger J, Eberhard O, Koch KM, Olbricht CJ (1997) Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. J Am Soc Nephrol 8:1722–1731PubMed Gwinner W, Landmesser U, Brandes RP, Kubat B, Plasger J, Eberhard O, Koch KM, Olbricht CJ (1997) Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. J Am Soc Nephrol 8:1722–1731PubMed
20.
Zurück zum Zitat Ghiselli A, Serafini M, Natella F, Scaccini C (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 29:1106–1114CrossRefPubMed Ghiselli A, Serafini M, Natella F, Scaccini C (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 29:1106–1114CrossRefPubMed
21.
Zurück zum Zitat Moran EC, Kamiguti AS, Cawley JC, Pettitt AR (2002) Cytoprotective antioxidant activity of serum albumin and autocrine catalase in chronic lymphocytic leukemia. Br J Haematol 116:316–328PubMed Moran EC, Kamiguti AS, Cawley JC, Pettitt AR (2002) Cytoprotective antioxidant activity of serum albumin and autocrine catalase in chronic lymphocytic leukemia. Br J Haematol 116:316–328PubMed
22.
Zurück zum Zitat Fydryk J, Jacobson E, Kurzawska O, Malecka G, Gonet B, Urasinski T, Brodkiewicz A, Bukowska H (1998) Antioxidant status of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 12:751–754CrossRefPubMed Fydryk J, Jacobson E, Kurzawska O, Malecka G, Gonet B, Urasinski T, Brodkiewicz A, Bukowska H (1998) Antioxidant status of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 12:751–754CrossRefPubMed
23.
Zurück zum Zitat Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V (2001) Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 54:356–362CrossRefPubMed Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V (2001) Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 54:356–362CrossRefPubMed
24.
Zurück zum Zitat Iscan A, Yigitoglu R, Vurgun N, Uyanik BS, Akyildiz M (1998) Low levels of high density lipoprotein cholesterol in Turkish children: an important risk factor. Acta Paediatr Jpn 40:41–46PubMed Iscan A, Yigitoglu R, Vurgun N, Uyanik BS, Akyildiz M (1998) Low levels of high density lipoprotein cholesterol in Turkish children: an important risk factor. Acta Paediatr Jpn 40:41–46PubMed
25.
Zurück zum Zitat Kinra S, Rath B, Kabi BC (2000) Indirect quantification of lipid peroxidation in steroid responsive nephrotic syndrome. Arch Dis Child 82:76–78CrossRefPubMed Kinra S, Rath B, Kabi BC (2000) Indirect quantification of lipid peroxidation in steroid responsive nephrotic syndrome. Arch Dis Child 82:76–78CrossRefPubMed
26.
Zurück zum Zitat bin Ali A, Zhang Q, Lim YK, Fang D, Retnam L, Lim SK (2003) Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation. Free Radic Biol Med 34:824–829CrossRefPubMed bin Ali A, Zhang Q, Lim YK, Fang D, Retnam L, Lim SK (2003) Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation. Free Radic Biol Med 34:824–829CrossRefPubMed
27.
Zurück zum Zitat Frishberg Y, Toledano H, Becker-Cohen R, Feigin E, Halle D (2000) Genetic polymorphism in paraoxonase is a risk factor childhood focal segmental glomerulosclerosis. Am J Kidney Dis 36:1253–1261PubMed Frishberg Y, Toledano H, Becker-Cohen R, Feigin E, Halle D (2000) Genetic polymorphism in paraoxonase is a risk factor childhood focal segmental glomerulosclerosis. Am J Kidney Dis 36:1253–1261PubMed
28.
Zurück zum Zitat Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M, Mackness M (2003) Low paraoxonase activity predict coronary events in the Caerphylly Prospective Study. Circulation 107:2775–2779CrossRefPubMed Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M, Mackness M (2003) Low paraoxonase activity predict coronary events in the Caerphylly Prospective Study. Circulation 107:2775–2779CrossRefPubMed
29.
Zurück zum Zitat Volk T, Schmutzler M, Engelhardt L, Pantke U, Laule M, Stangl K, Grune T, Wernecke KD, Konertz W, Kox WJ (2003) Effects of different steroid treatment on reperfusion-associated production of reactive oxygen species and arrhythmias during coronary surgery. Acta Anaesthesiol Scand 47:667–674 Volk T, Schmutzler M, Engelhardt L, Pantke U, Laule M, Stangl K, Grune T, Wernecke KD, Konertz W, Kox WJ (2003) Effects of different steroid treatment on reperfusion-associated production of reactive oxygen species and arrhythmias during coronary surgery. Acta Anaesthesiol Scand 47:667–674
Metadaten
Titel
Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome
verfasst von
Aydın Ece
Yıldız Atamer
Fuat Gürkan
Mehmet Davutoğlu
Yüksel Koçyiğit
Murat Tutanç
Publikationsdatum
01.09.2005
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 9/2005
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-005-1956-z

Weitere Artikel der Ausgabe 9/2005

Pediatric Nephrology 9/2005 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.